COA 214265 matches Janoshik Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
The portal confirms the certificate. It can't show that a vial you buy from Peptuvia is from this batch — compare the lot on yours.
5X9DNCQIS949This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 15 mg · Lab measured 17.74 mg
118% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 4.4 mg using the measured mass, against 3.8 mg on the label — 18% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 214265 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Janoshik Labs's portal shows validity only |
| Weight | Listed for information — supplier-provided, not counted |
HPLC purity analysis of Retatrutide 15mg sold by Peptuvia, ordered by its supplier and performed by Janoshik Labs on August 11, 2026. Reported purity: 99.529%. Net content: 17.74 mg against 15 mg labeled (118% of label). Tested content exceeds the labeled amount by 18%. Batch PSRETA15-1. Sample source: supplier-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| TRRT20260704 | 4 Aug 2026 | Janoshik Labs | 99.523% | 103% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion